AstraZeneca’s Tezspire receives approval for asthma treatment
Green light for new asthma pen which offers self-administration option across the EU
Read More
Tag: tezspire
AstraZeneca’s Tezspire approved in the EU for patients with severe asthma
Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
